BioSig Technologies signs LOI to merge with Streamex; Streamex stockholders to own 75% of combined company

Streamex Corp.

Streamex stockholders receive 19.9% of BSGM common stock plus Series X convertible preferred, totaling 75% ownership on conversion.
Board expands to 6 members: 4 designated by Streamex, 2 by BioSig; Karl McPhie becomes CEO, Morgan Lekstrom Chairman.
Anthony Amato to resign as CEO; combined company to seek at least $5M equity capital after closing.
Merger subject to due diligence, definitive agreements, Nasdaq and SEC approval; 60-day exclusivity period with break-up fee provisions.
BioSig to hold special stockholder meeting to approve share issuance and related proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.